Rapid onset of M184V mutation and phenotypic resistance to stavudine in zidovudine pre-treated HIV-1-infected individuals receiving the therapeutic regimens zidovudine plus lamivudine or stavudine plus lamivudine

被引：0
|
作者：
Rusconi, S
Milazzo, L
Testa, L
Catamancio, SL
Galazzi, M
Kurtagic, S
Citterio, P
Gianotto, M
Adorni, F
d'Arminio-Monforte, A
Galli, M
Moroni, M
机构：
[1] Univ Milan, Osped Luigi Sacco, Ist Malattie & Trop, Milan, Italy
[2] CNR, Ist Tecnol Biomed Avanzate, I-20131 Milan, Italy
来源：
AIDS | 1998年 / 12卷
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
P24
引用
收藏
页码：S23 / S23
页数：1
相关论文
共 8 条
  • [1] Evidence of stavudine-related phenotypic resistance among zidovudine-pretreated HIV-1-infected subjects receiving a therapeutic regimen of stavudine plus lamivudine
    Milazzo, L
    Rusconi, S
    Testa, L
    La Seta-Catamancio, S
    Galazzi, M
    Kurtagic, S
    Citterio, P
    Gianotto, M
    Grassini, A
    Adorni, F
    d'Arminio-Monforte, A
    Galli, M
    Moroni, M
    [J]. JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 1999, 22 (01): : 101 - 103
  • [2] Emergence of dual resistance to zidovudine and lamivudine in HIV-1-infected patients treated with zidovudine plus lamivudine as initial therapy
    Kuritzkes, DR
    Shugarts, D
    Bakhtiari, M
    Poticha, D
    Johnson, J
    Rubin, M
    Gingeras, TR
    Kennedy, M
    Eron, JJ
    [J]. JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2000, 23 (01): : 26 - 34
  • [3] Development and significance of the HIV-1 reverse transcriptase M184V mutation during combination therapy with lamivudine, zidovudine, and protease inhibitors
    Catucci, M
    Venturi, G
    Romano, L
    Riccio, ML
    De Milito, A
    Valensin, PE
    Zazzi, M
    [J]. JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 1999, 21 (03): : 203 - 208
  • [4] Evolution of antiretroviral phenotypic and genotypic drug resistance in antiretroviral-naive HIV-1-infected children treated with abacavir/lamivudine, zidovudine/lamivudine or abacavir/zidovudine, with or without nelfinavir (the PENTA 5 trial)
    Gibb, DM
    Walker, AS
    Kaye, S
    De Rossi, A
    Ait-Khaled, M
    Pillay, D
    Muñoz-Fernandez, MA
    Loveday, C
    Compagnucci, A
    Dunn, DT
    Babiker, AG
    [J]. ANTIVIRAL THERAPY, 2002, 7 (04) : 293 - 303
  • [5] Pressure of zidovudine accelerates the reversion of lamivudine resistance-conferring M184V mutation in the reverse transcriptase of human immunodeficiency virus type 1
    Diallo, K
    Oliveira, M
    Moisi, D
    Brenner, B
    Wainberg, MA
    Götte, M
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2002, 46 (07) : 2254 - 2256
  • [6] Impact of the M184V Resistance Mutation on Virological Efficacy and Durability of Lamivudine-Based Dual Antiretroviral Regimens as Maintenance Therapy in Individuals With Suppressed HIV-1 RNA: A Cohort Study
    Gagliardini, Roberta
    Ciccullo, Arturo
    Borghetti, Alberto
    Maggiolo, Franco
    Bartolozzi, Dario
    Borghi, Vanni
    Pecorari, Monica
    Di Biagio, Antonio
    Callegaro, Anna Paola
    Bruzzone, Bianca
    Saladini, Francesco
    Paolucci, Stefania
    Maserati, Renato
    Zazzi, Maurizio
    Di Giambenedetto, Simona
    De Luca, Andrea
    [J]. OPEN FORUM INFECTIOUS DISEASES, 2018, 5 (06):
  • [7] Reduced Emergence of the M184V/I Resistance Mutation When Antiretroviral-Naive Subjects Use Emtricitabine Versus Lamivudine in Regimens Composed of Two NRTIs Plus the NNRTI Efavirenz
    McColl, Damian J.
    Margot, Nicolas
    Chen, Shan-Shan
    Harris, Jeanette
    Borroto-Esoda, Katyna
    Miller, Michael D.
    [J]. HIV CLINICAL TRIALS, 2011, 12 (02): : 61 - 70
  • [8] Quadruple Nucleos(t)ide Reverse Transcriptase Inhibitors-Only Regimen of Tenofovir Plus Zidovudine/Lamivudine/Abacavir in Heavily Pre-Treated HIV-1 Infected Patients: Salvage Therapy or Backbone Only?
    Stephan, Christoph
    Dauer, Brenda
    Khaykin, Pavel
    Stuermer, Martin
    Gute, Peter
    Klauke, Stephan
    Staszewski, Schlomo
    [J]. CURRENT HIV RESEARCH, 2009, 7 (03) : 320 - 326
1